LT
The startup develops curative therapies that modulate cell metabolism to create immunotherapeutic compounds targeting cancer, mitochondrial diseases, and immune-related neurological disorders. By focusing on metabolic processes, the company provides the medical industry with effective treatment options for complex diseases that currently lack adequate therapies.
Updated 2 months ago
Funding
$5.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops curative therapies that modulate cell metabolism to create immunotherapeutic compounds targeting cancer, mitochondrial diseases, and immune-related neurological disorders. By focusing on metabolic processes, the company provides the medical industry with effective treatment options for complex diseases that currently lack adequate therapies.